These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1980848

  • 21. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
    Miller DB, O'Callaghan JP.
    Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
    [Abstract] [Full Text] [Related]

  • 22. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors.
    Millan MJ, Colpaert FC.
    Eur J Pharmacol; 1991 Feb 07; 193(2):145-52. PubMed ID: 1675609
    [Abstract] [Full Text] [Related]

  • 23. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW, Rempel N, Peng RY, Geyer MA.
    Neuropsychopharmacology; 1992 Sep 07; 7(2):113-27. PubMed ID: 1358088
    [Abstract] [Full Text] [Related]

  • 24. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR.
    J Psychopharmacol; 2004 Sep 07; 18(3):412-6. PubMed ID: 15358986
    [Abstract] [Full Text] [Related]

  • 25. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ, Black CK, Taylor VL.
    Eur J Pharmacol; 1991 Oct 02; 203(1):41-9. PubMed ID: 1686766
    [Abstract] [Full Text] [Related]

  • 26. Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M, Hanson GR, Gibb JW.
    Neuropharmacology; 1988 Nov 02; 27(11):1089-96. PubMed ID: 3144655
    [Abstract] [Full Text] [Related]

  • 27. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR, McKenna DJ, Peroutka SJ.
    Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011
    [Abstract] [Full Text] [Related]

  • 28. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
    Sprague JE, Banks ML, Cook VJ, Mills EM.
    J Pharmacol Exp Ther; 2003 Apr 25; 305(1):159-66. PubMed ID: 12649364
    [Abstract] [Full Text] [Related]

  • 29. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
    Nash JF.
    Life Sci; 1990 Apr 25; 47(26):2401-8. PubMed ID: 1979830
    [Abstract] [Full Text] [Related]

  • 30. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ, Ali SF, Daniels LG, Meyer JS.
    Synapse; 2010 Jun 25; 64(6):421-31. PubMed ID: 20169574
    [Abstract] [Full Text] [Related]

  • 31. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN, Yamamoto BK.
    J Pharmacol Exp Ther; 2010 Oct 25; 335(1):180-9. PubMed ID: 20634423
    [Abstract] [Full Text] [Related]

  • 32. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 33. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT, Nash JF, Meltzer HY.
    Eur J Pharmacol; 1989 Apr 12; 163(1):157-61. PubMed ID: 2472965
    [Abstract] [Full Text] [Related]

  • 34. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
    Johnson BN, Yamamoto BK.
    Neuroscience; 2009 Apr 10; 159(4):1233-43. PubMed ID: 19409219
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
    Finnegan KT, Calder L, Clikeman J, Wei S, Karler R.
    Brain Res; 1993 Feb 12; 603(1):134-8. PubMed ID: 8095837
    [Abstract] [Full Text] [Related]

  • 38. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").
    Colado MI, Granados R, O'Shea E, Esteban B, Green AR.
    Pharmacol Toxicol; 1999 Jun 12; 84(6):261-6. PubMed ID: 10401727
    [Abstract] [Full Text] [Related]

  • 39. 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.
    Miller RT, Lau SS, Monks TJ.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):173-80. PubMed ID: 9128836
    [Abstract] [Full Text] [Related]

  • 40. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 04; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.